procyanidin has been researched along with Carcinogenesis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, H; Chen, Y; Ma, B; Na, W; Shi, S; Zhan, Y; Zhang, H | 1 |
| He, X; Li, M; Liu, G; Shen, X; Shi, A; Tao, Y; Tu, Q; Wang, N; Wang, Q; Yin, C; Yin, H | 1 |
| Banwait, JK; Goel, A; Sharma, GG; Sharma, P; Shimura, T | 1 |
| Balaji, U; Cardenas, J; Goel, A; Gu, J; Pasham, D; Ravindranathan, P; Toden, S | 1 |
4 other study(ies) available for procyanidin and Carcinogenesis
| Article | Year |
|---|---|
Procyanidin B1, a novel and specific inhibitor of Kv10.1 channel, suppresses the evolution of hepatoma.
Topics: Animals; Biflavonoids; Carcinogenesis; Carcinoma, Hepatocellular; Catechin; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Hep G2 Cells; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Proanthocyanidins; Protein Structure, Secondary; Protein Structure, Tertiary; Tumor Burden; Xenograft Model Antitumor Assays | 2020 |
Polyphenolic Proanthocyanidin-B2 suppresses proliferation of liver cancer cells and hepatocellular carcinogenesis through directly binding and inhibiting AKT activity.
Topics: Animals; Apoptosis; Carcinogenesis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Liver Neoplasms; Mice; Molecular Docking Simulation; Phosphatidylinositol 3-Kinases; Proanthocyanidins; Proto-Oncogene Proteins c-akt | 2020 |
Enhanced anti-cancer activity of andrographis with oligomeric proanthocyanidins through activation of metabolic and ferroptosis pathways in colorectal cancer.
Topics: Andrographis; Animals; Antioxidants; Apoptosis; Carcinogenesis; Cell Line, Tumor; Colorectal Neoplasms; Diterpenes; Drug Therapy, Combination; Ferroptosis; Humans; Male; Mice; Mice, Nude; Organoids; Plant Extracts; Proanthocyanidins; Xenograft Model Antitumor Assays | 2021 |
A combination of curcumin and oligomeric proanthocyanidins offer superior anti-tumorigenic properties in colorectal cancer.
Topics: Animals; Anticarcinogenic Agents; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Curcumin; Drug Interactions; Endoplasmic Reticulum Chaperone BiP; Humans; Mice; Organoids; Polymerization; Proanthocyanidins; Safety; Xenograft Model Antitumor Assays | 2018 |